Latest Breaking News On - Primary sclerosing - Page 4 : comparemela.com

Pliant Therapeutics Presents Data from its Bexotegrast Program at the European Association for the Study of the Liver (EASL) International Liver Congress™

Presentations highlight preclinical and clinical advancements of bexotegrast program in primary sclerosing cholangitis SOUTH SAN FRANCISCO, Calif., June 23, 2023 (GLOBE NEWSWIRE) Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnolog.

Christopher keenanInternational liver congressDrug administrationCorporate communicationsEuropean medicines agencyPliant therapeutics incEuropean associationChief medical officerPrimary sclerosingData safety monitoring boardHuman liver explant tissueDual integrinRat modelPrivate securities litigation reform actPliant therapeuticsFinancial condition

Autoimmune Liver Disease Forum to Examine Solutions for Improving Health Outcomes

/PRNewswire/ A two-day virtual event on March 15th and 16th will bring together more than 350 patients, caregivers, hepatologists, primary care providers,.

United statesDouglast dieterichJulie kimbroughAparna goelLorraine stiehlDivision of liver diseasesGroup onInstitute for liver medicineAmerican liver foundationIcahn school of medicine at mount sinaiAutoimmune liver disease forumDepartment of medicineAutoimmune liver diseaseChief executive officerAmerican liverClinical associate professor

AJG Publishes Data from HighTide Therapeutics Phase 2 Study of HTD1801 Treatment in Primary Sclerosing Cholangitis

AJG Publishes Data from HighTide Therapeutics Phase 2 Study of HTD1801 Treatment in Primary Sclerosing Cholangitis
jcnnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jcnnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesJeffrey daoLiping liuKris kowdleyLiver instituteHightide therapeutics incNational major new drug innovation programAsia corporate news networkHightide therapeutic phasePrimary sclerosingAmerican journalMytide therapeuticsLiver institute northwestChief executive officerHightide therapeuticsFast track

AJG publishes HighTide Therapeutics Phase 2 Study of HTD1801

American Journal of Gastroenterology Publishes Data from HighTide Therapeutics Phase 2 Study of HTD1801 Treatment in Primary Sclerosing Cholangitis

United statesLiping liuKris kowdleyLiver instituteHightide therapeutics incHightide therapeutic phaseGastroenterology publishes dataPrimary sclerosingMytide therapeuticsAmerican journalLiver institute northwestChief executive officerHightide therapeutics

acnnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from acnnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesJeffrey daoLiping liuKris kowdleyLiver instituteHightide therapeutics incNational major new drug innovation programHightide therapeuticsHightide therapeutic phasePrimary sclerosingAmerican journalMytide therapeuticsLiver institute northwestChief executive officerFast trackOrphan drug